DermTech SG&A Expenses 2017-2023 | DMTK
DermTech sg&a expenses from 2017 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| DermTech Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $89 |
| 2022 | $95 |
| 2021 | $62 |
| 2020 | $30 |
| 2019 | $15 |
| 2019 | $ |
| 2018 | $6 |
| 2018 | $ |
| 2017 | $ |
| 2017 | $ |
| 2016 | $ |
| DermTech Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $17 |
| 2023-09-30 | $16 |
| 2023-06-30 | $28 |
| 2023-03-31 | $27 |
| 2022-12-31 | $23 |
| 2022-09-30 | $23 |
| 2022-06-30 | $24 |
| 2022-03-31 | $24 |
| 2021-12-31 | $20 |
| 2021-09-30 | $16 |
| 2021-06-30 | $14 |
| 2021-03-31 | $12 |
| 2020-12-31 | $8 |
| 2020-09-30 | $8 |
| 2020-06-30 | $8 |
| 2020-03-31 | $6 |
| 2019-12-31 | $5 |
| 2019-09-30 | $5 |
| 2019-06-30 | $3 |
| 2019-03-31 | $2 |
| 2018-12-31 | |
| 2018-09-30 | $2 |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.022B | $0.015B |
| DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.960B | 15.55 |
| Cencora (COR) | United States | $44.706B | 17.43 |
| ICON (ICLR) | Ireland | $25.718B | 24.28 |
| DiDi Global (DIDIY) | China | $23.622B | 0.00 |
| Avantor (AVTR) | United States | $16.493B | 24.28 |
| CochLear (CHEOY) | Australia | $14.172B | 0.00 |
| Viatris (VTRS) | United States | $14.062B | 4.04 |
| Revvity (RVTY) | United States | $12.689B | 22.26 |
| Charles River Laboratories (CRL) | United States | $12.120B | 22.09 |
| Medpace Holdings (MEDP) | United States | $12.009B | 39.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.810B | 0.00 |
| Natera (NTRA) | United States | $11.552B | 0.00 |
| Solventum (SOLV) | United States | $11.460B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.363B | 0.00 |
| HealthEquity (HQY) | United States | $6.693B | 50.01 |
| Organon (OGN) | United States | $5.239B | 4.97 |
| Bausch + Lomb (BLCO) | Canada | $5.204B | 20.86 |
| Doximity (DOCS) | United States | $4.455B | 33.17 |
| PACS (PACS) | United States | $3.704B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.453B | 31.59 |
| Sotera Health (SHC) | United States | $3.175B | 15.58 |
| Progyny (PGNY) | United States | $3.091B | 51.87 |
| GoodRx Holdings (GDRX) | United States | $3.006B | 152.20 |
| Life Times (LTH) | United States | $2.911B | 30.50 |
| Premier (PINC) | United States | $2.350B | 8.79 |
| AMN Healthcare Services Inc (AMN) | United States | $2.284B | 7.39 |
| Agilon Health (AGL) | United States | $2.134B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.069B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.948B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.725B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.407B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.296B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.715B | 7.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Embecta (EMBC) | United States | $0.591B | 3.90 |
| InnovAge Holding (INNV) | United States | $0.579B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.548B | 0.00 |
| CareDx (CDNA) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.527B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.503B | 0.00 |
| Enhabit (EHAB) | United States | $0.487B | 48.50 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| MultiPlan (MPLN) | United States | $0.391B | 0.00 |
| ModivCare (MODV) | United States | $0.373B | 6.99 |
| DocGo (DCGO) | United States | $0.365B | 19.44 |
| Sera Prognostics (SERA) | United States | $0.302B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.264B | 0.00 |
| Sharecare (SHCR) | United States | $0.250B | 0.00 |
| Biodesix (BDSX) | United States | $0.178B | 0.00 |
| So-Young (SY) | China | $0.137B | 46.00 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 7.13 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |